CHDArrhythmiasDiabetesLipidologyHeart FailureHypertensionStrokeThrombosis
Log in
Username
Password
Remember me
Content managed by and international Editorial Board, chaired by Professor Desmond Julian
Bookmark this site|Register Me|Forgotten Password
Welcome to InCirculation.net
InCirculation.net is a professional cardiovascular resource intended for a global audience of specialists, generalists, researchers, and other healthcare professionals
Would you like to know what else InCirculation.net has to offer? Take the tour of InCirculation.net
Click here to register

Cardiovascular News



Page summary
Text size
News quick search
Cardiovascular news provides daily news updates to help you stay informed.
 

Mild BNP may indicate LV dysfunction in diabetics


2 September 2010

MedWire News: Dutch researchers report that slightly elevated B-type natriuretic peptide (BNP) levels are associated with increased left ventricular (LV) mass and diastolic dysfunction in patients with Type 2 diabetes.

This association persists irrespective of age and other traditional cardiovascular disease (CVD) risk factors, and is also present, but less pronounced, in patients without diabetes.

Katja van den Hurk and colleagues from the VU University Medical Center in Amsterdam, say their findings imply “that potential risk estimations based on BNP levels should take the presence or absence of Type 2 diabetes into account, since it amplifies the associations.”

The team recruited 197 participants with normal glucose metabolism (NGM), 128 patients with impaired glucose metabolism (IGM), and 204 patients with Type 2 diabetes.

All patients had normal LV wall motion and BNP levels <50 pmol/l (median 4.2 pmol/l).

As reported in the European Journal of Heart Failure, van den Hurk and colleagues found that BNP levels positively correlated with LV mass and LV diastolic dysfunction, with a mean LV mass of 37 and 45 g/m2.7 among males and 39 and 43 g/m2.7 among females with BNP levels <2.8 and >6.7 pmol/l, respectively.

Of note, age and blood pressure also increased with BNP.

After adjustment for CVD risk factors such as age and smoking, the team found a stronger association between elevated BNP levels and LV diastolic dysfunction among patients with diabetes compared with those with IGM or NGM.

The researchers say that their findings imply that “the higher CVD and mortality risk associated with higher BNP levels in a non-heart failure (HF) range [of <200 pmol/l] result from a deteriorated LV diastolic function and LV hypertrophy but not from LV systolic function.”

They conclude that the mildly elevated BNP levels in patients with diabetes may help identify and treat Type 2 diabetes patients at high risk for CVD mortality.

MedWire (www.medwire-news.md) is an independent clinical news service provided by Current Medicine Group, a trading division of Springer Healthcare Limited. © Springer Healthcare Ltd; 2010

Eur J Heart Fail 2010; 12: 958–965



© Copyright Springer Healthcare Ltd, 2012

Related Content

Congress Reports
AHA 2011

EASD 2011

Your opinion matters – help to shape the future of InCirculation.net by completing our short survey. Click here!

To receive our weekly newsletter, register or update your profile. Click here!
All rights reserved. This website is intended for an international audience. Privacy PolicyLegal NoticeTerms and Conditions